Search for: "LUPIN PHARMACEUTICALS, INC."
Results 81 - 100
of 120
Sort by Relevance
|
Sort by Date
10 May 2010, 10:37 am
Lupin Pharmaceuticals, Inc. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
21 Mar 2010, 9:55 pm
Lupin Ltd. et al. 1:10-cv-00661; filed March 17, 2010 in the District Court of Maryland • Plaintiffs: Cephalon, Inc.; Cephalon France • Defendants: Lupin Ltd.; Lupin Pharmaceuticals, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in… [read post]
23 Feb 2010, 9:01 pm
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
21 Feb 2010, 8:25 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals, Inc. [read post]
17 Feb 2010, 8:00 am
Lupin Ltd. and Lupin Pharmaceuticals Inc. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
10 Feb 2010, 4:47 pm
Lupin Pharmaceuticals, Inc. et al. [read post]
9 Feb 2010, 8:35 pm
• Defendants: Lupin, Ltd.; Lupin Pharmaceuticals, Inc. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
21 Jan 2010, 1:00 am
Lupin, Ltd. et al. [read post]
9 Dec 2009, 3:59 pm
Lupin Pharmaceuticals, Inc. et al. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
9 Oct 2009, 9:11 am
Lupin Limited and Lupin Pharmaceuticals Inc. [read post]
21 Sep 2009, 2:30 am
Patent holder Eli Lilly and Company has claimed infringement by Sandoz, Inc. and others. [read post]
